Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia	Hemic and Lymphatic Diseases, anemia, hematologic disorder	Enrolling by invitation	Not applicable	2025-04-13		NCT01881503

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Englewood Hospital and Medical Center	7
HbO2 Therapeutics LLC	1

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Englewood Hospital and Medical Center	Englewood	United States	51

Clinical trials